Blocking endogenous glypican-3 expression releases Hep 3B cells from G1 arrest

Molecules and Cells

Volumn 15, Issue 3, 2003, Pages 356-360

  Farooq, Mohammad ^a   Hwang, Sun Young ^a   Park, Mi Kyung ^a   Kim, Jung Chul ^a   Kim, Moon Kyu ^a   Sung, Young Kwan ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Cell cycle arrest; Glypican 3; Hep 3B; Hep G2; Hepatoma cell line

Indexed keywords

GLYPICAN; GLYPICAN 3; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG; ANTISENSE OLIGONUCLEOTIDE; LIPID; LIPOFECTAMINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOHYDRATE ANALYSIS; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; ANIMAL; CELL CULTURE; CELL DIVISION; CELL LINE; COMPARATIVE STUDY; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; RAT;

ANIMALIA;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CELL LINE; G1 PHASE; GLYPICANS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; LIPIDS; MICE; OLIGONUCLEOTIDES, ANTISENSE; RATS; TUMOR CELLS, CULTURED;

EID: 2142857253     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cano-Gauci, D. F., Song, H. H., Yang, H., McKerlie, C., Choo, B., Shi, W., Pullano, R., Piscione, T. D., Grisaru, S., Soon, S., Sedlackova, L., Tanswell, A. K., Mak, T. W., Yeger, H., Lockwood, G. A., Rosenblum, N. D., and Filmus, J. (1999) Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. J. Cell Biol. 146, 255-264.
2. Chiao, E., Fisher, P., Crisponi, L., Deiana, M., Dragatsis, I., Schlessinger, D., Pilia, G., and Efstratiadis, A. (2002) Over-growth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling. Dev. Biol. 243, 185-206.
3. Gonzalez, A. D., Kaya, M., Shi, W., Song, H., Testa, J. R., Penn, L. Z., and Filmus, J. (1998) OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner. J. Cell Biol. 141, 1407-1414.
4. Grisaru, S., Cano-Gauci, D., Tee, J., Filmus, J., and Rosenblum, N. D. (2001) Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis. Dev. Biol. 231, 31-46.
5. Hsu, H. C., Cheng, W., and Lai, P. L. (1997) Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution. Cancer Res. 57, 5179-5184.
6. Hughes-Benzie, R. M., Pilia, G., Xuan, J. Y., Hunter, A. G., Chen, E., Golabi, M., Hurst, J. A., Kobori, J., Marymee, K., Pagon, R. A., Punnett, H. H., Schelley, S., Tolmie, J. L., Wohlferd, M. M., Grossman, T., Schlessinger, D., and MacKenzie, A. E. (1996) Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families. Am. J. Med Genet. 11, 227-234
7. Jackson, S. M., Nakato, H., Sugiura, M., Jannuzi, A., Oakes, R., Kaluza, V., Golden, C., and Selleck, S. B. (1997) dally, a Drosophila glypican, controls cellular responses to the TGF-beta-related morphogen, Dpp. Development 124, 4113-4120.
8. Lin, H., Huber, R., Schlessinger, D., and Morin, P. J. (1999) Frequent silencing of the GPC3 gene in ovarian cancer cell lines. Cancer Res. 59, 807-810.
9. Midorikawa, Y., Ishikawa, S., Iwanari, H., Imamura, T., Sakamoto, H., Miyazono, K., Kodama, T., Makuuchi, M., and Aburatani, H. (2003) Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int. J. Cancer 103, 455-465.
10. Murthy, S. S., Shen, T., De Rienzo, A., Lee, W. C., Ferriola, P. C., Jhanwar, S. C., Mossman, B. T., Filmus, J., and Testa, J. R. (2000) Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma. Oncogene 19, 410-416.
11. Paine-Saunders, S., Viviano, B. L., Zupicich, J., Skarnes, W. C., and Saunders, S. (2000) Glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development. Dev. Biol. 225, 179-187.
12. Park, J. G., Lee, J. H., Kang, M. S., Park, K. J., Jeon, Y. M., Lee, H. J., Kwon, H. S., Park, H. S., Yeo, K. S., Lee, K. U., Kim, S. T., Chung, J. K., Hwang, Y. J., Lee, H. S., Kim, C. Y., Lee, Y. I., Chen, T. R., Hay, R. J., Song, S. Y., Kim, W. H., Kim, C. W., and Kim, Y. I. (1995) Characterization of cell lines established from human hepatocellular carcinoma. Int. J. Cancer 62, 276-282.
13. Pilia, G., Hughes-Benzie, R. M., MacKenzie, A., Baybayan, P., Chen, E. Y., Huber, R., Neri, G., Cao, A., Forabosco, A., and Schlessinger, D. (1996) Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat. Genet. 12, 241-247.
14. Saikali, Z. and Sinnett, D. (2000) Expression of glypican 3 (GPC3) in embryonal tumors. Int. J. Cancer 89, 418-422.
15. Seo, J., Kim, J., and Kim, M. (2001) Cloning of androgen-inducible gene 1 (AIG1) from human dermal papilla cells. Mol. Cells 11, 35-40.
16. Song, H. H., Shi, W., and Filmus, J. (1997) OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2. J. Biol. Chem. 272, 7574-7577.
17. Sung, Y. K., Moon, C., Yoo, J. Y., Moon, C., Pearse, D., Pevsner, J., and Ronnett, G. V. (2002) Plunc, a member of the secretory gland protein family, is up-regulated in nasal respiratory epithelium after olfactory bulbectomy. J. Biol. Chem. 277, 12762-12769.
18. Sung, Y. K., Hwang, S. Y., Park, M. K., Farooq, M., Han, I. S., Bae, H. I., Kim, J. C., and Kim, M. K. (2003) Glypican-3 is overexpressed. in human hepatocellular carcinoma. Cancer Sci. 94, 259-262.
19. Toretsky, J. A., Zitomersky, N. L., Eskenazi, A. E., Voigt, R. W., Strauch, E. D., Sun, C. C., Huber, R., Meltzer, S. J., and Schlessinger, D. (2001) Glypican-3 expression in Wilms tumor and hepatoblastoma. J. Pediatr Hematol. Oncol. 23, 496-499.
20. Xiang, Y. Y., Ladeda, V., and Filmus, J. (2001) Glypican-3 expression is silenced in human breast cancer. Oncogene 20, 7408-7412.
21. Zhu, Z. W., Friess, H., Wang, L., Abou-Shady, M., Zimmermann, A., Lander, A. D., Korc, M., Kleeff, J., and Buchler, M. W. (2001) Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. Gut 48, 558-564.